Glaxosmithkline Share News (GSK)

GlaxoSmithKline And ViiV Receive Positive CHMP In EU For HIV Treatment

EU agency backs new drugs from GSK, Gilead, Otsuka

LONDON, Nov 22 (Reuters) - European regulators said on Friday they had recommended approval of a new drug for HIV from GlaxoSmithKline and a novel hepatitis C treatment from Gilead Sciences. The European Medicine Agency (EMA) also gave a green light to an Otsuka tuberculosis drug, following

GlaxoSmithKline To Invest GBP25 Million To Expand Operations In Scotland

Friday newspaper round-up: WTO, Serco, National Grid

Negotiators are poised to seal the first global trade deal for more than a decade, in a rare victory for the World Trade Organisation, whose struggle to secure an international pact has increasingly threatened its relevance. The US and powerful developing-nation players, including China and India, h

London midday: Markets in the red with BoE, Fed in focus

- BoE voted unanimously on policy at last meeting - MPC attempts to play down rate-hike fears - Taper in focus ahead of FOMC minutes techMARK 2,627.20 -0.64% FTSE 100 6,670.70 -0.41% FTSE 250 15,181.39 -0.55% UK markets were trading in the red on Wednesday after the Bank of England expressed conce

STOCKS NEWS EUROPE-MS picks European winners from China reforms

Europe's consumer, healthcare and technology companies should win out from the sweeping reforms in China, reckons Morgan Stanley, citing the commitment to a market economy, as well as the relaxation of the one child policy and the hukou household registration system. To capitalise on this,

London open: Investors turn cautious ahead of FOMC minutes

- Bernanke comments in focus ahead of FOMC minutes - Telecom Plus buys back businesses from Npower - Diageo CEO warns of 'uncertain' global economy techMARK 2,637.85 -0.24% FTSE 100 6,687.39 -0.16% FTSE 250 15,243.72 -0.14% UK stocks declined on Wednesday as investors adopted a cautious approach a

Glaxo Completes Aspen Stake Sale For GBP425 Million

London pre-open: FTSE called to open lower ahead of Fed and BoE minutes

City sources predict the FTSE 100 will open around 21 points lower than yesterday's close of 6,698.01, ahead of the release of the minutes from both the Bank of England and the latest meeting of the US Federal Reserve. The Federal Open Market Committee's meeting should offer further insight behind

GlaxoSmithKline completes sale of Aspen shares, raising $694 mln

LONDON, Nov 20 (Reuters) - GlaxoSmithKline said on Wednesday it had completed the sale of 28.2 million shares in Aspen Pharmacare at 250 rand each, raising gross proceeds of 7.059 billion rand ($694 million). Shares in the South African drugmaker closed at 267.40 rand on Tuesday. GSK

GSK completes sale of stake in Aspen Pharmacare

GlaxoSmithKline (GSK) has completed the partial sale of Aspen Pharmacare, the drug company announced on Wednesday. The group has disposed 28.2m ordinary shares in Aspen at a price of 250 South African Rand (ZAR) per share, raising gross proceeds of 7,059m ZAR. The sale will leave GSK with 56.5m or

MARKET COMMENT: UK Stocks Close Mixed Ahead Of Fed Minutes

UPDATE 1-GlaxoSmithKline to divest $740 mln stake in S.Africa's Aspen

* GSK aims to realise some value from 4-year investment * Plans to sell one-third of holding, keep 13 pct stake LONDON, Nov 19 (Reuters) - GlaxoSmithKline said on Tuesday it planned to reduce its investment in South African drugmaker Aspen Pharmacare by one third, although it would re

REPEAT: Glaxo Cashes In On Some Of The Value Growth It's Seen In Aspen

Glaxo Cashes In On Some Of The Value Growth It's Seen In Aspen